Shionogi & Co., Ltd. (FRA:SH0)

Market Cap	12.95B +1.4%
Revenue (ttm)	2.73B +14.0%
Net Income	1.12B +20.4%
EPS	1.31 +20.3%
Shares Out	n/a
PE Ratio	11.57
Forward PE	n/a
Dividend	0.39 (2.69%)
Ex-Dividend Date	Mar 30, 2026

Volume	n/a
Open	14.50
Previous Close	14.68
Day's Range	14.50 - 14.61
52-Week Range	12.70 - 19.40
Beta	n/a
Analysts	n/a
Price Target	n/a
Earnings Date	May 12, 2026

About Shionogi &

Shionogi & Co., Ltd. engages in the research, development, manufacture, and distribution of pharmaceuticals, diagnostic reagents, and medical devices in Japan and internationally. It is also involved in consumer healthcare business; manufacturing, sale, analytical testing, and pharmaceutical engineering of medicinal drugs and investigational drugs; contracted monitoring of epidemiological components in sewage; promotion of implementation in social infrastructure; and business related to providing data and information; develops and sells foothol...

• Industry: Pharmaceutical Preparations
• Founded: 1878
• Employees: 4,955
• Stock Exchange: Frankfurt Stock Exchange
• Ticker Symbol: SH0

Financial Performance

In fiscal year 2026, Shionogi &'s revenue was 499.68 billion, an increase of 14.01% compared to the previous year's 438.27 billion. Earnings were 205.16 billion, an increase of 20.37%.

Financial numbers in JPY